Last updated on December 2019

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recently Diagnosed Type 1 Diabetes Mellitus (T1D)

Find a site near you

Start Over

Yale Center for Clinical Investigation

New Haven, CT United States
  Connect »